SBRT 2016

Risk adapted fractionation

• Operable patient with stage I NSCLC • Peripheral location

Total Dose

3 x 18Gy

• Oligoprogressive stage IV NSCLC • Central location

Relevance of long-term LC

5 x 7Gy

# of fractions

Dose to critical serial OARs

Matthias Guckenberger - ESTRO SBRT Course 2016 Athens

13.06.2016

23

/